Literature DB >> 28324753

Error augmentation feedback for lateral weight shifting.

Kevin O'Brien1, Charles R Crowell2, James Schmiedeler3.   

Abstract

This study examines the effect of error augmentation of center of pressure (CoP) visual feedback on the performance of a lateral weight shifting task. Error augmentation emphasizes deviations from a standard CoP trajectory generated from existing data of over 2000 weight shifts collected with young, healthy subjects. Thirty-six subjects completed nine lateral weight shifting sessions, of which four were training sessions between each of the five testing sessions. Half of the subjects received error augmentation feedback during the training sessions, while the other half received the unaltered, control feedback. The change in visual feedback did not affect the final steady state weight shifting performance. Instead, error augmentation feedback was found to drive subjects to their steady-state performance sooner than unaltered visual feedback. The emphasis on deviations from the standard trajectory with error augmentation appears to lead to reduced variation in shifting. This finding may be useful in generating novel therapies that improve the efficiency of balance rehabilitation.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Center of pressure; Error augmentation; Lateral balance; Time-to-target; Visual feedback

Mesh:

Year:  2017        PMID: 28324753     DOI: 10.1016/j.gaitpost.2017.03.003

Source DB:  PubMed          Journal:  Gait Posture        ISSN: 0966-6362            Impact factor:   2.840


  2 in total

1.  The effects of ratio in the multifidus muscle thickness according to various angle of mediolateral ramp during double stance.

Authors:  Sang-Yeol Lee
Journal:  J Phys Ther Sci       Date:  2017-09-15

2.  Cortical reorganization to improve dynamic balance control with error amplification feedback.

Authors:  Yi-Ching Chen; Yi-Ying Tsai; Gwo-Ching Chang; Ing-Shiou Hwang
Journal:  J Neuroeng Rehabil       Date:  2022-01-16       Impact factor: 4.262

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.